SvijetVijesti

Srbija: Do sada 755 neželjenih reakcija na vakcine protiv koronavirusa

U Srbiji je do sada prijavljeno 755 neželjenih reakcija na vakcine protiv koronavirusa, što je jedna prijavljena reakcija na 3.973 imunizovanih građana, izjavio je predstavnik Agencije za lekove i medicinska sredstva Pavle Zelić.

“Sve reakcije su bile blage – otok, crvenilo, bol, visoka temperatura, bol u mišićima, mučnina“, objasnio je Zelić za Radio-televiziju Srbije i dodao da to nije ništa zabrinjavajuće.

U Srbiji je dostupna imunizacija vakcinama Sinopharm, Pfizer/BioNTech, AstraZeneca i Sputnik V, a Zelić je kazao da Moderna još nije podnela zahtev za registraciju, da su u toku pregovori, te da očekuje da će se i ona naći u ponudi.

On je naveo i da vakcina ima sasvim dovoljno, jer je više od 3,5 miliona doza do sada stiglo u Srbiju.

0 0 vote
Article Rating

Show More
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
Back to top button
0
Would love your thoughts, please comment.x
()
x

Our website uses cookies and thereby collects information about your visit to improve our website (by analyzing), show you Social Media content and relevant advertisements. Please see our page for furher details or agree by clicking the 'Accept' button.

Cookie settings

Below you can choose which kind of cookies you allow on this website. Click on the "Save cookie settings" button to apply your choice.

FunctionalOur website uses functional cookies. These cookies are necessary to let our website work.

AnalyticalOur website uses analytical cookies to make it possible to analyze our website and optimize for the purpose of a.o. the usability.

Social mediaOur website places social media cookies to show you 3rd party content like YouTube and FaceBook. These cookies may track your personal data.

AdvertisingOur website places advertising cookies to show you 3rd party advertisements based on your interests. These cookies may track your personal data.

OtherOur website places 3rd party cookies from other 3rd party services which aren't Analytical, Social media or Advertising.